CD163 and rectal neoplasm: Recent findings by Wilkins et al. demonstrated that baseline immune gene expression profiling can stratify rectal tumours into radioresistant and radiosensitive phenotypes, with poor responders showing an upregulation of stromal and immunosuppressive genes such as CD274 (PD-L1), IL6R, and CD163, which were associated with inferior outcomes [76].